YOSHIKO INAMOTO
YOSHIKO INAMOTO publishes mostly in Organic Chemistry, Pharmacology and Molecular Biology, on topics such as Synthesis and Biological Evaluation, Antibiotics Pharmacokinetics and Efficacy and Synthesis and Characterization of Heterocyclic Compounds.
- World rank
- #3,732,787 of 7,710,434 ranked researchers
- Rank in Japan
- #95,419 of 383,136
- Works
- 21
- Citations
- 330
- Citations per work
- 15.7
What does YOSHIKO INAMOTO research?
YOSHIKO INAMOTO's work is mostly in Chemistry (34%), Medicine (28%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences734.4%
- Chemistry734.4%
- Health Sciences627.9%
- Medicine627.9%
- Everything else522.9%
- Life Sciences314.8%
- 1Organic Chemistry34% of their works
- 2Pharmacology23% of their works
- 3Molecular Biology7% of their works
- 4Toxicology5% of their works
- 5Oncology5% of their works
- 6Biotechnology3% of their works
Research topics
- Synthesis and Biological Evaluation
- Antibiotics Pharmacokinetics and Efficacy
- Synthesis and Characterization of Heterocyclic Compounds
- Microbial Natural Products and Biosynthesis
- Bioactive Compounds and Antitumor Agents
- Synthesis and biological activity
- Synthesis of β-Lactam Compounds
- Drug-Induced Adverse Reactions
Which keywords describe YOSHIKO INAMOTO's research?
The keywords of their largest research topics: Anticancer Agents, Biological Evaluation, Synthesis, Heterocyclic Compounds, Medicinal Chemistry, Drug Discovery, Derivatives and Quinoxaline.
- Vascular Targeting Agents
- Toxicology
- Stereocontrolled Synthesis
- HLA-B*5701
- Triazines
- Natural Products
- Critically Ill Patients
- Quinoxaline
- Drug Discovery
- Heterocyclic Compounds
- Biological Evaluation
- Anticancer Agents
- Synthesis
- Medicinal Chemistry
- Derivatives
- Antibiotic Pharmacokinetics
- Antimicrobial
- Secondary Metabolites
- Asymmetric Catalysis
- Quinones
- Stevens-Johnson Syndrome
- Tubulin Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Anticancer Agents164 topics
- Biological Evaluation143 topics
- Synthesis143 topics
- Heterocyclic Compounds102 topics
- Medicinal Chemistry102 topics
- Drug Discovery82 topics
- Derivatives71 topic
- Quinoxaline71 topic
- Antibiotic Pharmacokinetics51 topic
- Critically Ill Patients51 topic
- Antimicrobial41 topic
- Natural Products41 topic
- Secondary Metabolites41 topic
- Triazines41 topic
- Asymmetric Catalysis31 topic
- HLA-B*570131 topic
- Quinones31 topic
- Stereocontrolled Synthesis31 topic
- Stevens-Johnson Syndrome31 topic
- Toxicology31 topic
- Tubulin Inhibitors31 topic
- Vascular Targeting Agents31 topic
Where does YOSHIKO INAMOTO work?
YOSHIKO INAMOTO's main affiliation in the publication record is Fujisawa City Hospital, Japan.
How many publications and citations does YOSHIKO INAMOTO have?
OpenAlex counts 21 works and 330 citations for YOSHIKO INAMOTO, an h-index of 7, ranking #3,732,787 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about YOSHIKO INAMOTO. Posts are plain text and can be reported.